Jump to content

Frequency of Antibody Workups--revisited


cbaldwin

Recommended Posts

I apologize for posting because this subject has been covered many times.  Before posting I read some of the related threads, and I think I am on the right track, but I just want to make sure.

 

I have a specific situation, and 2 specific questions:

 

The situation:

 

Patient, GI bleeder, is O, Rh negative.  Patient received 2 units O, Rh negative pRBCs on 4/2/15 at another facility. 

 

On 4/10/15 the patient shows up at our small hospital, where we only perform tube ABO/Rh and manual gel antibody screens.  Antibody screen is weakly positive.

 

We send the specimen to our reference lab where a weak anti-Jka is identified.  However, the patient stabilizes at 9.0 hgb  and does not receive any blood products.  Patient is discharged 4/12/15.

 

On 4/18/15 I receive a call from the patient’s physician.  The patient has been bleeding.  His hemoglobin is 6.5.  The physician would like to order 2 units O, Rh negative units that are negative for Jka and transfuse the patient.

 

I tell the physician that because the patient was transfused so recently (4/2/15) and because the antibody workup was done on blood drawn 4/10/15, that, on 4/18/15, I would need to draw another sample and send the specimen to the reference lab for a repeat antibody workup.  The patient may have developed another antibody.  This is the policy at our facility.

 

We ended up sending the patient to a larger facility capable of a higher level of medical care.

 

My first question:

Was I correct about needing to test for additional antibodies?  A knowledgeable friend suggested it would have been okay to transfuse Jka negative units that were compatible at IgG....but but but... how could I be sure that another weak antibody wasn't lurking?   I think Malcolm has covered this subject in a related thread--the donor cells may be single-dose,  etc etc. 

 

I am looking at AABB Standards 5.14.3.2 and 5.14.3.3--A specimen from a patient that has been transfused in the last 3 months is only good for 3 days and patients with previously identified antibodies must be tested with a method to identify additional clinically significant antibodies.  A 3-cell antibody screen is not really a good method to identify additional antibodies

 

My second question:

In AABB Standard 5.14.3.2, how did the creators of this standard decide on three months?

 

I appreciate any comments and advice.  And thanks for your patience at revisiting this subject again!!!!

 

Catherine

Link to comment
Share on other sites

Let's answer question # 2 first. In any given unit of donated blood, the red cells are of all ages, new and older. So, since the life span of the RBC in the circulation is approximately 90 days, "recently transfused" means that there is a possibility of donor red cells still in circulation in the patient - therefore, foreign antigens are present that could elicit an antibody response up to 90 days (approx.).

Question #1 - I think you were correct in requesting another antibody work up. Especially with the severe drop in Hgb. If a patient has been recently transfused - with in 3 months, the specimen is only good to work with for 4 days - the day it's drawn plus 3.

Assuming you don't do antibody work ups at your hospital, I believe this patient needed an additional work up at the reference lab.

The 3 month rule is because the body can form an antibody to a foreign antigen at any time that foreign (donated) red cells are actively in the patient's circulation.

I hope that helps, and I'm sure my reference lab colleagues will have more to say :)

Liz

Link to comment
Share on other sites

R1R2,

 

No, our antibody screen on 4/18 showed the Jka reaction was definitely stronger.  

 

Also, I did not mention this before, in order not to distract from my main question, there was an antibody present to the 0.8% screening cell preservative. 

 

When we performed the gel antibody screen with our usual 0.8% cells, all cells were positive at 2+.  The auto and DAT were negative, and when I XM'd all of our (8) units of O negative units, those XM's were compatible at gel IgG.  So I suspected an antibody to the preservative in the 0.8% cells.  As a backup, we have 3% antibody screening cells for tube, and I made 0.8% cells from these cells.  The antibody screen with the 3% cells made into 0.8% cells was negative. 

 

On 4/18 I ran a antibody screen with the 0.8% cells and the 3% cells made into 0.8% cells.  The 0.8% cells showed the Jka antibody and the antibody to the preservative.  The 3% cells made into the 0.8% and tested with gel IgG showed just the Jka.

Link to comment
Share on other sites

HI, I am concerned about the antibody to the preservatives- can anyone recommend a good source of general information on this?  I have to wonder how many "nonspecific antibodies" we see on the Echo or in tube that are actually antibodies to a preservative. I have the thread about the 'solid phase antibodies" but have zero knowledge of manual tube testing possible preservative issues. All resources welcomed, thanks!

Link to comment
Share on other sites

R1R2,

 

No, our antibody screen on 4/18 showed the Jka reaction was definitely stronger.  

 

Also, I did not mention this before, in order not to distract from my main question, there was an antibody present to the 0.8% screening cell preservative. 

 

When we performed the gel antibody screen with our usual 0.8% cells, all cells were positive at 2+.  The auto and DAT were negative, and when I XM'd all of our (8) units of O negative units, those XM's were compatible at gel IgG.  So I suspected an antibody to the preservative in the 0.8% cells.  As a backup, we have 3% antibody screening cells for tube, and I made 0.8% cells from these cells.  The antibody screen with the 3% cells made into 0.8% cells was negative. 

 

On 4/18 I ran a antibody screen with the 0.8% cells and the 3% cells made into 0.8% cells.  The 0.8% cells showed the Jka antibody and the antibody to the preservative.  The 3% cells made into the 0.8% and tested with gel IgG showed just the Jka.

Thanks for the additional info.   Additional testing was warranted.    

Link to comment
Share on other sites

Also, the 0.8% Ortho red cells have a preservative in them that may effect patients with allergies to sulfa drugs. I'm at home now, and don't have the package insert in front of me, but the preservatives are different from the 3% cells and the 0.8% "gel ready" cells. Check to see if your patient has a sulfa allergy, that may explain the reaction differences you are seeing.

Liz

Link to comment
Share on other sites

  • 2 weeks later...

goodchild, how about a DAT positive (4+) I had once, with an underlying anti-Vel, which I only knew about when I looked up the patient's past history?  Turned my own blood cold when I realised!!!!!!!!  Thank God we had seen the patient in the past, otherwise I suspect that we would not have seen the patient in the future!!!!!!!!

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.
  • Advertisement

×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.